By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Octapharma USA, Inc. 

13800 Coppermine Road

Herndon  Virginia  20170  U.S.A.
Phone: 703-234-5375 Fax:



Company News
FDA Grants Octapharma USA Orphan Drug Designation For Octagam10% For The Treatment Of Dermatomyositis 5/17/2017 11:31:33 AM
Octapharma USA Research Results Presented At HTRS Symposium Targeting Major Challenges Facing Hemophilia Patients 4/20/2017 12:48:29 PM
Octapharma USA Sponsors ‘Hope Ignites: Stories To Inspire’ Program At Hemophilia Federation Of America Annual Symposium 4/7/2017 11:14:24 AM
Octapharma USA Grant Supports First National Conference For Type 3 von Willebrand Disease Patients 4/3/2017 8:44:27 AM
Octapharma USA Launches Co-Pay Assistance Program For Patients Receiving Octagam 5% And Octagam 10% 1/26/2017 12:08:03 PM
Octapharma USA Announces Two Hemophilia A Clinical Trials To Utilize WILATE 11/14/2016 11:29:49 AM
Octapharma USA Announces U.S. Availability Of NUWIQ To Treat Adults And Children With Hemophilia A 1/4/2016 10:31:05 AM
FDA Green Lights Octapharma USA's NUWIQ for Hemophilia A 9/15/2015 10:27:04 AM
Octapharma USA, Inc.: FDA Approves WILATE License Supplement – Perioperative Management Of Bleeding In Patients With Von Willebrand Disease 8/13/2015 10:19:37 AM
Octapharma USA, Inc.: FDA Approves Octaplas License Supplement, Increasing Post Thaw Permitted Storage Time 3/9/2015 10:27:43 AM